Niagen Bioscience (NAGE) Beginning Cash Balance (2012 - 2018)

Niagen Bioscience (NAGE) has 7 years of Beginning Cash Balance data on file, last reported at $45.4 million in Q1 2018.

• Beginning Cash Balance for Q1 2018 came in at $45.4 million, up 2664.25% year-over-year; the trailing twelve-month figure through Mar 2018 was $47.0 million (up 553.97% YoY), and the FY2013 annual result was $520000.0, up 23.76% from the prior year.
• Beginning Cash Balance grew to $45.4 million in Q1 2018 per NAGE's latest filing, from $429.0 in the prior quarter.
• Over five years, Beginning Cash Balance peaked at $45.4 million in Q1 2018 and troughed at $429.0 in Q3 2017.
• A 5-year average of $9.8 million and a median of $3.1 million in 2014 frame the typical range for Beginning Cash Balance.
• The sharpest annual moves came in 2017 and 2018: Beginning Cash Balance slumped 70.41% in 2017, then jumped 2664.25% in 2018.
• A 5-year view of Beginning Cash Balance shows it stood at $2.3 million in 2014, then surged by 75.33% to $4.0 million in 2015, then surged by 39.98% to $5.5 million in 2016, then sank by 99.99% to $429.0 in 2017, then surged by 10580086.48% to $45.4 million in 2018.
• Business Quant data shows NAGE's Beginning Cash Balance at $45.4 million in Q1 2018, $429.0 in Q3 2017, and $1.6 million in Q2 2017.